Rebalance is a drug owned by PEGASUS LABORATORIES, INC. It is protected by 3 US drug patents filed in 2016. All patents have expired. Details of Rebalance’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6448252 | 17 Jul, 2016 | Expired |
About Rebalance
Rebalance is a drug
owned by PEGASUS LABORATORIES, INC.
Rebalance uses
Pyrimethamine, Sulfadiazine Sodium as the active
ingredients.
Active Ingredient:
Rebalance uses
Pyrimethamine,
Sulfadiazine Sodium
as the active ingredients.
Check out other Drugs and Companies using
Pyrimethamine, Sulfadiazine Sodium ingredient.